PubMed COVID-19 Clinical Care

The clinical manifestation of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the respiratory system of humans is widely recognized. There is increasing evidence suggesting that SARS-CoV-2 possesses the

CONCLUSIONS: This paper provides a methodology for selecting adequate settings for the large-scale piloting of eHealth frameworks and exemplifies with the decisions taken in GATEKEEPER the current views of the WHO and European Commission while moving

To effectively design policies and implement measures for addressing problems faced by people during these difficult times of pandemic, it is critical to have a clear vision of the problems people are freely talking about. One of the ways is to

CONCLUSION: In the medical literature, many articles have mentioned the association of GBS with the Coronavirus, and it is considered the most common peripheral neurologic complication for the virus, but this article is considered one of the very few

CONCLUSIONS: While the effects of medications on anti-SARS-CoV-2 antibody titers in patients with IBD were consistent across sites, geographical location conferred the highest risk of susceptibility to serologically detectable SARS-CoV-2 infection

CONCLUSION: Together, our study identifies microbiome-derived tonic signaling tuned by psychological stress to imprint resident immune cells and defensive response in the lungs. Further studies are warranted to translate these findings, basically

Hyper-secretion and/or hyper-concentration of mucus is a defining feature of multiple obstructive lung diseases, including chronic obstructive pulmonary disease (COPD). Mucus itself is composed of a mixture of water, ions, salt and proteins, of which

CONCLUSION: The graph-based RF model registered high performance in classifying the symptoms of COVID-19 infection, thereby indicating that the graph data science, in conjunction with ML techniques, helps improve performance and accelerate

CONCLUSION: This work is one of the few studies that quantitatively explores the evolutionary characteristics of global government policies on COVID-19, and our results provide some new perspectives on global policy activity levels and evolution

CONCLUSION: In the past 10 years, papers in the field of pharmaceutical care have shown a significant growth trend and scholars have become increasingly interested in research on related content in the field of pharmaceutical care. Our research